TIC markers cells in different pancreatic tumors and cell lines
Nature of sample | CD133 (% positive) | CD44/24/ESA (% positive) | Aldh activity (net) (% positive) | |
---|---|---|---|---|
KPC001 | Cell line | 8% (±1.8%) | 4.3% (±1.6%) | 2.2% (±1.1%) |
KPC023 | Cell line | 7.1% (±1.2%) | 3.8% (±1.2%) | 1.8% (±0.8%) |
KPC883 | Tumor | 6.9% | 4.1% | 0.9% |
KPC820 | Tumor | 8.2% | 3.2% | 1.1% |
KPC793 | Tumor | 7.8% | 2.6% | 0.8% |
AsKPC883 | Ascitis | 2.2% | 0 | 0 |
AsKPC820 | Ascitis | 2.8% | 0 | 0 |
AsKPC793 | Ascitis | 2.1% | 0 | 0 |
Liver001 | Cell line | 2.4% (±0.7%) | 0.5% (±0.2%) | 0.8 (±0.4%) |
hPDX1 | Tumor xenograft | 4.2% (±1.6%) | 1.2% (±0.3%) | 2.8% (±1.2%) |
hPDX2 | Tumor xenograft | 3.5% (±1.4%) | 0.8% (±0.3%) | 1.1% (±0.9%) |
hPDX3 | Tumor xenograft | 2.8% (±0.9%) | 0.3% (±0.2%) | 0.9% (±0.4%) |
hPDX4 | Tumor (fresh) | 4.5% | 0.2% | 0.8% |